key: cord-1052409-jqn6ihof
authors: Zarubin, Aleksei; Stepanov, Vadim; Markov, Anton; Kolesnikov, Nikita; Marusin, Andrey; Khitrinskaya, Irina; Swarovskaya, Maria; Litvinov, Sergey; Ekomasova, Natalia; Dzhaubermezov, Murat; Maksimova, Nadezhda; Sukhomyasova, Aitalina; Shtygasheva, Olga; Khusnutdinova, Elza; Radjabov, Magomed; Kharkov, Vladimir
title: Structural variability, expression profile and pharmacogenetics properties of TMPRSS2 gene as a potential target for COVID-19 therapy
date: 2020-06-20
journal: bioRxiv
DOI: 10.1101/2020.06.20.156224
sha: b3aa0023095f334401f257f4417a03c2295fe758
doc_id: 1052409
cord_uid: jqn6ihof

The human serine protease TMPRSS2 gene is involved in the priming of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins being one of the possible targets for COVID-19 therapy. TMPRSS2 gene is possibly co-expressed with SARS-CoV-2 cell receptor genes ACE2 and BSG, but only TMPRSS2 demonstrates tissue-specific expression in alveolar cells according to single cell RNA sequencing data. Our analysis of the structural variability of the TMPRSS2 gene based on genome-wide data of 76 human populations demonstrates that functionally significant missense mutation in exon 6/7 in TMPRSS2 gene, was found in many human populations in relatively high frequency, featuring region-specific distribution patterns. The frequency of the missense mutation encoded by the rs12329760, which previously was found to be associated with prostate cancer, is ranged between 10% and 63% being significantly higher in populations of Asian origin compared to European populations. In addition to SNPs, two copy numbers variants (CNV) were detected in the TMPRSS2 gene. Number of microRNAs have been predicted to regulate TMPRSS2 and BSG expression levels, but none of them is enriched in lung or respiratory tract cells. Several well studied drugs can downregulate the expression of TMPRSS2 in human cells, including Acetaminophen (Paracetamol) and Curcumin. Thus TMPRSS2 interaction with the SARS-CoV-2, its structural variability, gene-gene interactions, and expression regulation profiles, and pharmacogenomics properties characterize this gene as a potential target for COVID-19 therapy.

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a 2 pandemic of coronavirus diseases and lead to a global public health crisis. 3 Infection of the human cells with viral particles occurs through the binding of S viral 4 proteins to the receptors of the host cell and their subsequent priming with proteases. 5 ACE2 is considered the classic receptor for SARS-CoV-2, but there is evidence that it 6 can also use the BSG receptor (CD147) [33] . The priming of viral proteins is carried out 7 by the TMPRSS2 protease. No specific therapy has yet been developed for SARS-CoV-2. 8 But it was found that blockers of all three proteins can prevent cell infection [15] . 9 In addition to protein blocking, there are other mechanisms that can alter the 10 expression level or affinity of the interaction of viral particles with specific proteins. 11 Possible ways of expression differentiation include alteration of protein structure due to 12 genetic variants (SNV, INDEL), copy number variation (CNV), variants affecting 13 regulatory regions (eQTL), and epigenetic regulation (methylation, miRNA). 14 TMPRSS2 gene in humans encodes a transmembrane protein that belongs to the 15 serine protease family. Alternatively spliced transcript variants encoding different 16 isoforms have been found for this gene. TMPRSS2 protein involved in prostate 17 carcinogenesis via overexpression of ETS transcription factors, such as ERG and ETV1, 18 through gene fusion. TMPRSS2-ERG gene fusion, present in 40% -80% of prostate 19 cancers in humans, is one of the molecular subtypes that has been associated with 20 predominantly poor prognosis [25, 28] .

TMPRSS2 protease proteolytically cleaves and activates glycoproteins of many 22 viruses including spike proteins of human coronavirus 229E (HCoV-229E) and human 23 coronavirus EMC (HCoV-EMC); the fusion glycoproteins of Sendai virus (SeV), human 24 metapneumovirus (HMPV), human parainfluenza 1, 2, 3, 4a and 4b viruses 25 (HPIV) [1, 4, 13-15, 29, 30] . It has been shown that both the SARS coronavirus of 2003 26 severe acute respiratory syndrome outbreak in Asia (SARS-CoV) and the SARS-CoV-2 27 are activated by TMPRSS2 and can thus be inhibited by TMPRSS2 inhibitors [15] . In 28 this work, we report the data on genetic variability of TMPRSS2 gene in 76 human 29 populations of North Eurasia in comparison with worldwide populations; analyze the 30 data on expression and its regulation of TMPRSS2 gene, its interaction with 31 SARS-CoV-2 receptors, and its pharmacogenetic properties. 32 

Structural variability data 34 Allele frequency for worldwide populations were downloaded from GnomAD database 35 containing information on the frequencies of genomic variants from more than 120 36 thousand exomes and 15 thousand of whole genomes [18] . These data were used to 37 search SNVs and INDELs in TMPRSS2 gene. Data on copy number variation were 38 obtained from CNV Control Database [21] . 

Data on 4 missense mutations in TMPRSS2 gene were extracted from the dataset. CNV 53 search was performed using Markov model algorithm for high-resolution copy number 54 variation detection in whole-genome SNP implemented in PennCNV tool [34] . 55 To determine possible functional impact of detected SNVs, the Polymorphism 56 Phenotyping v2 (Poly-Phen-2) tool was used [2] . Poly-Phen estimates the impact of the 57 mutation on the stability and function of the protein using the structural and 58 evolutionary analyses of the amino acid substitution. The tool evaluates the probability 59 of the mutation to be probably damaging, possibly damaging, benign or of unknown 60 significance using quantitative prediction with a score.

Bioinformatics analysis of gene expression, miRNA intercaction 62 and pharmacogenomics 63 Analysis of protein -protein interactions of SARS-CoV-2 interacting proteins was 64 carried out using the GeneMANIA and STRING web resources [32, 38] . Single cell RNA 65 sequencing data were downloaded from the PanglaoDB database which contains more 66 than 1300 single cell sequencing samples [12] . Lung cells single cell RNA-seq data were 67 obtained from the Sequence Read Archive (SRA) [22] and processed in R software 68 environment using the Seurat package [31] .

Analysis of the interaction of miRNAs with target proteins was performed using 70 information from two databases, miRTarBase, which contains information from more 71 than 8000 referenced sources about experimentally confirmed micro RNA -protein 72 interactions [16] , and miRPathDB database containing experimentally confirmed and 73 predicted miRNA-protein interactions [19] . Data on the differential expression of 74 miRNAs in various cell cultures were downloaded from the database of the FANTOM5 75 project [10] . DRUGBANK database [35] was used to search for the drugs which may 76 change the level of protein expression. outgrowth of astrocytic processes [7, 24, 27] . BSG is which is involved in tumor 96 development, plasmodium invasion and virus infection [8, 17, 23, 26, 36, 37] . Previous 97 data on severe acute respiratory syndrome indicate that BSG plays a functional role in 98 facilitating SARS-CoV invasion for host cells, and CD147-antagonistic peptide-9 has a 99 high binding rate to HEK293 cells and an inhibitory effect on SARS-CoV [9] . Based on 100 the similarity of SARS-CoV and SARS-CoV-2, the function of BSG in invasion for host 101 cells by SARS-CoV-2 can be assumed. The exact role of BSG in COVID-19 is still 102 unknown, but recently it was found that CD147 may bind spike protein of 103 SARS-CoV-2 [33] . The preliminary data on a small sample of COVID-19 patients 104 demonstrated that Meplazumab, a humanized anti-CD147 antibody, efficiently improved 105 the recovery of patients with SARS-CoV-2 pneumonia with a favorable safety profile [6] . 106

Expression of ACE2, BSG and TMPRSS2 in single cells 107 Data on expression profiles of SARS-CoV-2-interacting genes in various tissues 108 demonstrates that ACE2 has a high level of expression only in testicles (Fig. 2a) .

Highest expression of BSG was found in germ cells, endothelium of various localization, 110 fibroblasts and some other cell types (Fig. 2b ). TMPRSS2 showed a high level of 111 expression in the prostate, intestines, and lungs (Fig. 2c) .

In addition, the expression of these proteins was analyzed in a single sample 113 (SRS2769051) of proximal stromal lung cells (Fig. 3 ). ACE2 had a low level of In order to study the population differentiation in TMPRSS2 functional variants in more 147 details, we searched for TMPRSS2 allelic frequency in our own unpublished data on 76 148 populations of North Eurasia based on 1836 samples genotyped using genome-wide 149 microarrays. Four missense mutations and two CNV in TMPRSS2 gene were found in 150 our dataset. We summarized the frequency of TMPRSS2 missense mutations in North 151 Eurasian population (Table 3 ) in comparison to worldwide data (Table 4) Table 4 ).

In addition, we detected CNV in 2 samples. In the first case, an increase in the 170 number of copies covering the entire gene was found in the Karanogai individual. According to the GTEx Analysis V8 database, the TMPRSS2 gene contains 136 eQTLs 183 (including 60 down-regulating and 76 up-regulating variants) that significantly alters its 184 expression in lung tissues (Table 5) According to the miRTarBase and miRPathDB databases, no experimentally proven 190 miRNAs regulating TMPRSS2 were detected. It is worth to note that TMPRSS2 and 191 BSG genes have the same predicted regulatory miRNAs. Two drugs from the list above (Acetaminophen / Paracetamol and Curcumin) were 203 also considered as a possible therapy for COVID-19 [3] . Acetaminophen is currently 204 being discussed as a possible drug for the correction of fever in patients with The discovered feature of this drug to reduce the level of expression of TMPRSS2 may 206 be an additional argument in favor of its use, compared with other NSAIDs. Curcumin, 207 a widely used food supplement, has the predicted ability to block Main Protease (Mpro) 208 of SARS-CoV-2 [20] , and may be studied further in relation to COVID-19 therapy. 

Tmprss2 is an activating protease for respiratory parainfluenza viruses

Predicting functional effect of human missense mutations using polyphen-2. Current protocols in human genetics

Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (covid-19)

Tmprss2 activates the human coronavirus 229e for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium

Status of tmprss2-erg fusion in prostate cancer patients from india: correlation with clinico-pathological details and tmprss2 met160val polymorphism

Meplazumab treats covid-19 pneumonia: an open-labelled

Juvenile cataract-associated mutation of solute carrier slc16a12 impairs trafficking of the protein to the plasma membrane

Redistribution of cyclophilin a to viral factories during vaccinia virus infection and its incorporation into mature particles

Function of hab18g/cd147 in invasion of host cells by severe acute respiratory syndrome coronavirus

An integrated expression atlas of mirnas and their promoters in human and mouse

Association of tmprss2-erg gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer

Panglaodb: a web server for exploration of mouse and human single-cell rna sequencing data

Evidence that tmprss2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response

Tmprss2 and adam17 cleave ace2 differentially and only proteolysis by tmprss2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein

Sars-cov-2 cell entry depends on ace2 and tmprss2 and is blocked by a clinically proven protease inhibitor

mirtarbase 2020: updates to the experimentally validated microrna-target interaction database

Cd147 promotes reprogramming of glucose metabolism and cell proliferation in hcc cells by inhibiting the p53-dependent signaling pathway

Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes

mirpathdb 2.0: a novel release of the mirna pathway dictionary database

Potential inhibitor of covid-19 main protease (mpro) from several medicinal plant compounds by molecular docking study

Comparative analysis of copy number variation detection methods and database construction

The sequence read archive

Basolateral cd147 induces hepatocyte polarity loss by e-cadherin ubiquitination and degradation in hepatocellular carcinoma progress

The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activity

The tmprss2: Erg rearrangement, erg expression, and prostate cancer outcomes: a cohort study and meta-analysis

Cd147 facilitates hiv-1 infection by interacting with virus-associated cyclophilin a

Type 2 diabetes variants disrupt function of slc16a11 through two distinct mechanisms

Tmprss2: Erg fusion identifies a subgroup of prostate cancers with a favorable prognosis

Middle east respiratory syndrome coronavirus infection mediated by the transmembrane serine protease tmprss2

A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry

Comprehensive integration of single-cell data

String v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets

Sars-cov-2 invades host cells via a novel route: Cd147-spike protein

Penncnv: an integrated hidden markov model designed for high-resolution copy number variation detection in whole-genome snp genotyping data

Drugbank 5.0: a major update to the drugbank database

Disrupting cd147-rap2 interaction abrogates erythrocyte invasion by plasmodium falciparum